Salem Investment Counselors’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-500
Closed -$38.6K – 662
2026
Q2
$38.6K Hold
500
– – ﹤0.01% 665
2026
Q1
$35.2K Buy
+500
New +$36.9K ﹤0.01% 669
2025
Q4
– Sell
-500
Closed -$33.4K – 648
2025
Q3
$33.4K Hold
500
– – ﹤0.01% 670
2025
Q2
$32K Hold
500
– – ﹤0.01% 660
2025
Q1
$34.2K Hold
500
– – ﹤0.01% 635
2024
Q4
$32.7K Sell
500
-100
-17% -$6.95K ﹤0.01% 655
2024
Q3
$43.7K Hold
600
– – ﹤0.01% 605
2024
Q2
$41.2K Hold
600
– – ﹤0.01% 600
2024
Q1
$41.9K Hold
600
– – ﹤0.01% 588
2023
Q4
$38.8K Hold
600
– – ﹤0.01% 590
2023
Q3
$36.3K Sell
600
-350
-37% -$22K ﹤0.01% 579
2023
Q2
$60K Buy
950
+350
+58% +$21.9K ﹤0.01% 495
2023
Q1
$36.9K Buy
600
+100
+20% +$6.21K ﹤0.01% 587
2022
Q4
$32K Hold
500
– – ﹤0.01% 585
2022
Q3
$29K Buy
+500
New +$30.7K ﹤0.01% 572

Other funds holding FHLC

Salem Investment Counselors's FHLC Position: Q3 2026 in Review

Salem Investment Counselors sold out of Fidelity MSCI Health Care Index ETF (FHLC) in Q3 2026, closing a stake of 500 shares — an estimated $38.6K sold.

Salem Investment Counselors first reported a position in FHLC in Q3 2022 and held it in 15 quarters. The position peaked at $60K in Q2 2023. 68 funds tracked by Wall St. Rank hold FHLC as of Q3 2026.

  • Salem Investment Counselors reported no remaining Fidelity MSCI Health Care Index ETF position as of Q3 2026 after selling out during the quarter.
  • Salem Investment Counselors sold 500 Fidelity MSCI Health Care Index ETF shares in Q3 2026, an estimated $38.6K.
  • Salem Investment Counselors first reported a position in Fidelity MSCI Health Care Index ETF in Q3 2022 and held it in 15 quarters.
  • Salem Investment Counselors's Fidelity MSCI Health Care Index ETF position peaked at $60K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q3 2026.

Based on Salem Investment Counselors's 13F filing for Q3 2026, filed 13 Oct 2026.